Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

  • Chi Ying F Huang (Contributor)
  • Ping Chieh Chou (Contributor)
  • Kuo-Chang Wen (Creator)
  • Mong Hong Lee (Contributor)
  • Jun-Hung Lin (Contributor)
  • Pi Lin Sung (Contributor)
  • Sai Ching J. Yeung (Contributor)
  • Alexander TH Wu (Creator)



Additional file 2: Figure S2. The effect of different concentrations of metformin in ovarian cancer cells. Tumor proliferation (2D-colony formation) of mouse ovarian cancer cells treated with different concentrations of metformin. Maximum plasma concentrations (Cmax) of Metformin was clinically around 1.03–4.12 mg/L ( ,021202s016lbl.pdf).
Date made available2020

Cite this